Chemoinformaics analysis of (1R)-2-methyl-5-propan-2-ylbicyclo[3.1.0]hex-2-ene
| Molecular Weight | 136.238 | nRot | 1 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
| Exact Molecular Weight | 136.125 | nRing | 2 |
| Solubility: LogS | -3.747 | nHRing | 0 |
| Solubility: LogP | 3.907 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.3687 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.486 |
| Synth | 4.391 |
| Natural Product Likeliness | 3.138 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.272 |
| MDCK | 0.0000253 |
| BBB | 0.403 |
| PPB | 0.903263 |
| VDSS | 2.251 |
| FU | 0.112216 |
| CYP1A2-inh | 0.763 |
| CYP1A2-sub | 0.374 |
| CYP2c19-inh | 0.248 |
| CYP2c19-sub | 0.898 |
| CYP2c9-inh | 0.135 |
| CYP2c9-sub | 0.195 |
| CYP2d6-inh | 0.08 |
| CYP2d6-sub | 0.365 |
| CYP3a4-inh | 0.284 |
| CYP3a4-sub | 0.295 |
| CL | 17.105 |
| T12 | 0.215 |
| hERG | 0.027 |
| Ames | 0.016 |
| ROA | 0.148 |
| SkinSen | 0.191 |
| Carcinogencity | 0.725 |
| EI | 0.985 |
| Respiratory | 0.481 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.906851 |